Stephen K. Brannan Karuna Therapeutics, Inc. (KRTX) insider trading activity

Stephen K. Brannan is Chief Medical Officer of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 42,604 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $14,059,320. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Stephen K. Brannan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 18 2024	SELL Sale (or disposition) back to the issuer	$14,059,320 $330.0 p/Share	42,604 Reduced 100.0%	0 Common Stock
Mar 08 2024	SELL Open market or private sale	$1,593,200 $318.64 p/Share	5,000 Reduced 10.5%	42,604 Common Stock
Mar 08 2024	BUY Exercise of conversion of derivative security	$622,650 $83.02 p/Share	7,500 Added 13.61%	47,604 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$331,728 $317.14 p/Share	1,046 Reduced 2.54%	40,104 Common Stock
Feb 08 2024	SELL Open market or private sale	$1,581,500 $316.3 p/Share	5,000 Reduced 10.83%	41,150 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	$440,325 $58.71 p/Share	7,500 Added 13.98%	46,150 Common Stock
Jan 08 2024	SELL Open market or private sale	$4,752,150 $316.81 p/Share	15,000 Reduced 27.96%	38,650 Common Stock
Jan 08 2024	BUY Exercise of conversion of derivative security	$1,452,850 $83.02 p/Share	17,500 Added 24.6%	53,650 Common Stock
Dec 08 2023	SELL Open market or private sale	$2,025,100 $202.51 p/Share	10,000 Reduced 21.67%	36,150 Common Stock
Dec 08 2023	BUY Exercise of conversion of derivative security	$856,875 $68.55 p/Share	12,500 Added 21.31%	46,150 Common Stock
Nov 08 2023	SELL Open market or private sale	$885,900 $177.18 p/Share	5,000 Reduced 12.94%	33,650 Common Stock
Nov 08 2023	BUY Exercise of conversion of derivative security	$514,125 $68.55 p/Share	7,500 Added 16.25%	38,650 Common Stock
Oct 09 2023	SELL Open market or private sale	$866,850 $173.37 p/Share	5,000 Reduced 13.83%	31,150 Common Stock
Oct 09 2023	BUY Exercise of conversion of derivative security	$514,125 $68.55 p/Share	7,500 Added 17.18%	36,150 Common Stock
Sep 08 2023	SELL Open market or private sale	$922,300 $184.46 p/Share	5,000 Reduced 14.86%	28,650 Common Stock
Sep 08 2023	BUY Exercise of conversion of derivative security	$514,125 $68.55 p/Share	7,500 Added 18.23%	33,650 Common Stock
Aug 08 2023	SELL Open market or private sale	$903,250 $180.65 p/Share	5,000 Reduced 16.05%	26,150 Common Stock
Aug 08 2023	BUY Exercise of conversion of derivative security	$514,125 $68.55 p/Share	7,500 Added 19.4%	31,150 Common Stock
Apr 10 2023	SELL Open market or private sale	$884,400 $176.88 p/Share	5,000 Reduced 17.45%	23,650 Common Stock
Apr 10 2023	BUY Exercise of conversion of derivative security	$46,000 $9.2 p/Share	5,000 Added 14.86%	28,650 Common Stock
Mar 09 2023	SELL Open market or private sale	$947,550 $189.51 p/Share	5,000 Reduced 17.45%	23,650 Common Stock
Mar 09 2023	BUY Exercise of conversion of derivative security	$27,250 $5.45 p/Share	5,000 Added 14.86%	28,650 Common Stock
Feb 09 2023	SELL Open market or private sale	$961,850 $192.37 p/Share	5,000 Reduced 25.0%	15,000 Common Stock
Feb 09 2023	BUY Exercise of conversion of derivative security	$27,250 $5.45 p/Share	5,000 Added 20.0%	20,000 Common Stock
Feb 09 2023	BUY Grant, award, or other acquisition	-	8,650 Added 26.78%	23,650 Common Stock

SKB

Stephen K. Brannan

Chief Medical Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX

Account